These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 3287904)

  • 1. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy.
    Couser WG
    Am J Kidney Dis; 1988 Jun; 11(6):449-64. PubMed ID: 3287904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis.
    Syed R; Rehman A; Valecha G; El-Sayegh S
    Biomed Res Int; 2015; 2015():402826. PubMed ID: 26688808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].
    Wang D; Wang F; Ding J; Xiao H; Zhong X; Liu X
    Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):670-5. PubMed ID: 26757967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement your knowledge with a rare cause of pauci-immune glomerulonephritis.
    Lomzenski H; Thibodaux R; Guevara M
    Clin Rheumatol; 2018 Nov; 37(11):3151-3155. PubMed ID: 30203317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular capillary and endothelial cell injury is associated with the formation of necrotizing and crescentic lesions in crescentic glomerulonephritis.
    Fujita E; Nagahama K; Shimizu A; Aoki M; Higo S; Yasuda F; Mii A; Fukui M; Kaneko T; Tsuruoka S
    J Nippon Med Sch; 2015; 82(1):27-35. PubMed ID: 25797872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapidly progressive glomerulonephritis in children.
    Moorani KN; Aziz M; Amanullah F
    Pak J Med Sci; 2022 Jan; 38(2):417-425. PubMed ID: 35310798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of plasma exchange in severe idiopathic rapidly progressive glomerulonephritis. A report of ten cases.
    Burran WP; Avasthi P; Smith KJ; Simon TL
    Transfusion; 1986; 26(4):382-7. PubMed ID: 3727013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
    Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
    Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly progressive crescentic glomerulonephritis: Early treatment is a must.
    Moroni G; Ponticelli C
    Autoimmun Rev; 2014 Jul; 13(7):723-9. PubMed ID: 24657897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerulonephritis.
    Couser WG
    Lancet; 1999 May; 353(9163):1509-15. PubMed ID: 10232333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapidly progressive glomerulonephritis due to anti-glomerular basement membrane disease accompanied by IgA nephropathy: An unusual association.
    Annamalai I; Chandramohan G; Srinivasa Prasad ND; Fernando E; Sujith S
    Saudi J Kidney Dis Transpl; 2017; 28(6):1404-1407. PubMed ID: 29265054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three Diseases Mediated by Different Immunopathologic Mechanisms-ANCA-Associated Vasculitis, Anti-Glomerular Basement Membrane Disease, and Immune Complex-Mediated Glomerulonephritis-A Common Clinical and Histopathologic Picture: Rapidly Progressive Crescentic Glomerulonephritis.
    Gluhovschi C; Gadalean F; Velciov S; Nistor M; Petrica L
    Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38001978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exchange in the treatment of rapidly progressive glomerulonephritis.
    Chen X; Chen N
    Contrib Nephrol; 2013; 181():240-7. PubMed ID: 23689585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical and pathological analysis of 41 patients with anti-glomerular basement membrane antibody related diseases].
    Zhao M; Ding J; Liu Y; Zou W; Wang H
    Zhonghua Nei Ke Za Zhi; 2001 May; 40(5):316-20. PubMed ID: 11798594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice.
    Huang XR; Tipping PG; Shuo L; Holdsworth SR
    Kidney Int; 1997 Jan; 51(1):94-103. PubMed ID: 8995722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapy of rapidly progressive glomerulonephritis.
    Sieberth HG; Maurin N
    Klin Wochenschr; 1983 Oct; 61(20):1001-10. PubMed ID: 6358652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CD8+ T cells in crescentic glomerulonephritis.
    Chen A; Lee K; Guan T; He JC; Schlondorff D
    Nephrol Dial Transplant; 2020 Apr; 35(4):564-572. PubMed ID: 30879039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STING1 deficiency ameliorates immune-mediated crescentic glomerulonephritis in mice.
    García-Giménez J; Córdoba-David G; Rayego-Mateos S; Cannata-Ortiz P; Carrasco S; Ruiz-Ortega M; Fernandez-Fernandez B; Ortiz A; Ramos AM
    J Pathol; 2023 Nov; 261(3):309-322. PubMed ID: 37650295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology and Outcome of Crescentic Glomerulonephritis From a Single Center in China: A 10-Year Review.
    Chen S; Tang Z; Xiang H; Li X; Chen H; Zhang H; Hu W; Zeng C; Liu Z
    Am J Kidney Dis; 2016 Mar; 67(3):376-83. PubMed ID: 26388283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies].
    Namba T; Hatanaka M; Takahashi A; Takeji M; Takahara K; Uzu T; Yamauchi A
    Nihon Jinzo Gakkai Shi; 2008; 50(1):64-8. PubMed ID: 18318246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.